Dalli, Jeffrey http://orcid.org/0000-0003-0170-3667
Shanahan, Sarah
Hardy, Niall P.
Chand, Manish
Hompes, Roel
Jayne, David
Ris, Frederic
Spinelli, Antonino
Wexner, Steven
Cahill, Ronan A.
Funding for this research was provided by:
The Disruptive Technologies Innovation Fund (DTIF), Enterprise Ireland
TESS - Tertiary Education Scholarship Scheme
University College Dublin
Article History
Received: 18 August 2021
Accepted: 23 April 2022
First Online: 11 May 2022
Declarations
:
: Prof. Ronan A Cahill is named on a patent filed in relation to processes for visual determination of tissue biology, receives speaker fees from Stryker Corp, Ethicon/J&J, and Olympus, research funding from Intuitive Corp, consultancy fees from Medtronic and Distalmotion, and holds research funding from the Irish Government (DTIF) in collaboration with IBM Research in Ireland and from EU Horizon 2020 in collaboration with Palliare and Steripak. Drs. Jeffrey Dalli and Niall P Hardy are employed as researchers in the DTIF and Dr. Jeffrey Dalli is recipient of the TESS scholarship (Malta). Dr. Manish Chand receives speaker fees from Ethicon/JnJ and Meril and is clinical advisor to Livsmed. Dr. Roel Hompes has an unrestricted research grant and materials from Stryker European Operations B.V. and receives speaker fees from Stryker Corp, Medtronic, and Applied Medical. Prof. David Jayne has received consulting honoraria from Stryker Corp. Prof Ris receives speaker fees from Stryker Corp, Arthrex, Hollister, and Ethicon/J&J and research funding from Ethicon/J&J and Quantgene. Prof. Antonino Spinelli acted as consultant and speaker for Takeda, Pfizer and Janssen, Sofar, and Oasis. Prof Steven Wexner receives royalties for intellectual property license from Medtronic, Intuitive, and Karl Storz and consulting fees for consulting from Stryker, Intuitive, and Olympus. Dr. Sarah Shanahan has no disclosures.